Skip to main content
SpringerLink
Log in

Further research on Xyrem®/sodium oxybate treatment of patients with obstructive sleep apnea is needed

  • Letter to the Editors
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. George CF, Feldman N, Zheng Y, Steininger TL, Grzeschik SM, Lai C, Inhaber N (2010) A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome. Sleep Breath. doi:10.1007/S11325-009-03200-0

    Google Scholar 

  2. Zvosec DL, Smith SW, Mahowald MW (2010) Rigorous study of Xyrem®/sodium oxybate use among patients with obstructive sleep apnea and other conditions of compromised respiratory function is critically needed. Sleep Medicine (in press)

  3. George CF, Feldman N, Inhaber N, Steininger TL, Grzeschik SM, Lai C, Zheng Y (2010) A safety trial of sodium oxybate in patients with obstructive sleep apnea: acute effects on sleep-disordered breathing. Sleep Med 11:38–42

    Article  PubMed  Google Scholar 

  4. Feldman NT (2010) Clinical perspective: monitoring sodium oxybate-treated narcolepsy patients for the development of sleep-disordered breathing. Sleep Breath 14:77–79

    Article  PubMed  Google Scholar 

  5. Kovacevic-Ristanovic R, Kuzniar TJ (2010) Use of sodium oxybate (Xyrem®) in patients with dual diagnosis of narcolepsy and sleep apnea. Sleep Med 11:5–6

    Article  PubMed  Google Scholar 

  6. Akins BE, Miranda E, Matthew Lacy J, Logan BK (2009) A multi-drug intoxication fatality involving Xyrem (GHB). J Forensic Sci 54:495–496

    Article  PubMed  Google Scholar 

  7. Zvosec DL, Smith SW, Hall BJ (2009) Three deaths associated with use of Xyrem®. Sleep Med 10:490–493

    Article  PubMed  Google Scholar 

  8. George C, Feldman N (2006) Effects of sodium oxybate (Xyrem®) on sleep-disordered breathing. Abstract P366. Sleep Medicine 7:S73

    Article  Google Scholar 

  9. Xyrem® (sodium oxybate) oral solution. Available at http://jazzph.isat-tech.com/media/PI.pdf. Accessed on Feb 5, 2009

  10. Mamelak M, Black J, Montplaisir J, Ristanovic R (2004) A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy. Sleep 27:1327–1334

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Emergency Medicine, Hennepin County Medical Center, 701 Park Avenue South, Minneapolis, MN, 55415, USA

    Deborah L. Zvosec

  2. Department of Emergency Medicine, Hennepin County Medical Center, 701 Park Avenue, Minneapolis, MN, 55415, USA

    Stephen W. Smith

  3. Department of Emergency Medicine, University of Minnesota Medical School, 717 Delaware St. SE, Minneapolis, MN, 55414, USA

    Stephen W. Smith

  4. Minnesota Regional Sleep Disorders Center and Department of Neurology, Hennepin County Medical Center, 701 Park Avenue, Minneapolis, MN, 55415, USA

    Mark W. Mahowald

  5. Department of Neurology, University of Minnesota Medical School, 420 Delaware St. SE, Minneapolis, MN, 55455, USA

    Mark W. Mahowald

Authors
  1. Deborah L. Zvosec
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen W. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mark W. Mahowald
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Deborah L. Zvosec.

Additional information

Dr. Zvosec and Dr. Smith have provided paid medico-legal testimony regarding health risks of GHB and its analogs, gamma butyrolactone (GBL), and 1,4 butanediol (BD). This testimony has not involved Xyrem®, or Jazz Pharmaceuticals, Inc., or Orphan Medical, Inc., (bought by Jazz Pharmaceuticals, Inc.) and has been related to cases involving illicit analog products (GBL and BD) and cases of GHB/analog-facilitated sexual assault. Dr. Mahowald has nothing to disclose.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zvosec, D.L., Smith, S.W. & Mahowald, M.W. Further research on Xyrem®/sodium oxybate treatment of patients with obstructive sleep apnea is needed. Sleep Breath 15, 619–620 (2011). https://doi.org/10.1007/s11325-010-0413-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-010-0413-9

Keywords

Search

Navigation